West Pharmaceutical ServicesWST +1.24%95 Shareholder Yield % is 1.44% as of Mar. 2026, which is 9% below its 10-year median of 1.58. GuruFocus rates WST with a GF Score™ of 95/100 and a GF Value™ of $361.62 (Fairly Valued). The stock has 9 warning signs investors should review. Among 817 Medical Devices & Instruments companies, West Pharmaceutical Services ranks better than 64.01% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, West Pharmaceutical Services's Shareholder Yield % was 1.44%.
West Pharmaceutical Services (NYSE:WST) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
West Pharmaceutical Services Shareholder Yield % Related Terms
West Pharmaceutical Services Shareholder Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
West Pharmaceutical Services Shareholder Yield % Chart
WST vs RMD, MDLN, SOLV: Shareholder Yield % Comparison
For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
West Pharmaceutical Services Shareholder Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where West Pharmaceutical Services's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
West Pharmaceutical Services (WST) has a Shareholder Yield % of 1.44% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on West Pharmaceutical Services and its competitors. This is near median its historical median of 1.58. Over the past decade, West Pharmaceutical Services' Shareholder Yield % has ranged from 0.38 to 3.46. According to the industry distribution chart, West Pharmaceutical Services ranks #294 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 36%.
Is West Pharmaceutical Services' Shareholder Yield % too high?
West Pharmaceutical Services' current Shareholder Yield % of 1.44% is near median its 10-year median of 1.58. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 3.46. The Medical Devices & Instruments industry median Shareholder Yield % is 0.14. West Pharmaceutical Services' value of 1.44% is 928.6% above this industry median. Based on the distribution chart, West Pharmaceutical Services ranks #294 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, West Pharmaceutical Services has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does West Pharmaceutical Services' Shareholder Yield % compare to RMD and MDLN?
According to the Medical Devices & Instruments industry distribution chart, West Pharmaceutical Services ranks #294 out of 817 companies for Shareholder Yield %. This puts West Pharmaceutical Services in the upper half of its industry. The industry median Shareholder Yield % is 0.14. West Pharmaceutical Services' value of 1.44% is 928.6% above this benchmark. Historically, West Pharmaceutical Services' own Shareholder Yield % has ranged from 0.38 to 3.46 over the past decade. While the company's 10-year median is 1.58 vs. the industry median of 0.14, West Pharmaceutical Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Devices & Instruments company?
The median Shareholder Yield % among Medical Devices & Instruments companies is 0.14, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. West Pharmaceutical Services's current Shareholder Yield % of 1.44% is 928.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on West Pharmaceutical Services and its competitors. For the Medical Devices & Instruments industry, the median Shareholder Yield % is 0.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. West Pharmaceutical Services's current Shareholder Yield % is 1.44%, which is near median its own 10-year median of 1.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is West Pharmaceutical Services stock overvalued right now?
Based on GuruFocus' analysis, West Pharmaceutical Services (WST) is currently considered Fairly Valued. The stock's GF Value™ is $361.62, compared to a current price of $350.85 — trading 3% below its estimated fair value. The current Shareholder Yield % is 1.44%, which is near median its 10-year median of 1.58 and 928.6% above the Medical Devices & Instruments industry median of 0.14. West Pharmaceutical Services' overall GF Score™ is 95/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For West Pharmaceutical Services (WST), the current Shareholder Yield % is 1.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is West Pharmaceutical Services (WST) Overvalued in 2026?
Based on GuruFocus' analysis, West Pharmaceutical Services stock appears to be undervalued.
The current stock price of $350.85 is trading 3% below its estimated GF Value™ of $361.62.
GuruFocus considers West Pharmaceutical Services to be Fairly Valued.
Key valuation signals for WST:
Shareholder Yield %: 1.44% (near median its 10-year median of 1.58)
GF Value™: $361.62 vs. price of $350.85 (3% below fair value)
Industry Position: 928.6% above the Medical Devices & Instruments median (#294 of 817)
No single metric tells the full story. See the WST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
95GF Score
Get the complete analysis for WST
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WST has been successfully added to your 
